Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

APREMILAST vs ROFLUMILAST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

APREMILAST vs ROFLUMILAST: Safety Overview

Metric APREMILAST ROFLUMILAST
Total FAERS Reports 136,713 2,700
Deaths Reported 4,704 645
Death Rate 3.4% 23.9%
Hospitalizations 9,544 625
Average Patient Age 54.0 yrs 68.8 yrs
% Female Patients 67.3% 56.3%
FDA Approval Date Apr 7, 2023 Apr 17, 2023
Manufacturer Amgen, Inc Aurobindo Pharma Limited
Route ORAL ORAL
Marketing Status Prescription Prescription